Alfuzosin 2.5mg tablets Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

alfuzosin 2.5mg tablets

mawdsley-brooks & company ltd - alfuzosin hydrochloride - oral tablet - 2.5mg

Alfuzosine Sandoz 5 mg tabl. prol.-rel. Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alfuzosine sandoz 5 mg tabl. prol.-rel.

sandoz sa-nv - alfuzosin hydrochloride 5 mg - prolonged-release tablet - 5 mg - alfuzosin hydrochloride 5 mg - alfuzosin

Alfuzosine Sandoz 10 mg tabl. prol.-rel. Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alfuzosine sandoz 10 mg tabl. prol.-rel.

sandoz sa-nv - alfuzosin hydrochloride 10 mg - prolonged-release tablet - 10 mg - alfuzosin hydrochloride 10 mg - alfuzosin

Xatral 5 Retard 5 mg tabl. prol.-rel. Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xatral 5 retard 5 mg tabl. prol.-rel.

sanofi belgium sa-nv - alfuzosin hydrochloride 5 mg - prolonged-release tablet - 5 mg - alfuzosin hydrochloride 5 mg - alfuzosin

Xatral Uno 10 mg tabl. prol.-rel. Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xatral uno 10 mg tabl. prol.-rel.

sanofi belgium sa-nv - alfuzosin hydrochloride 10 mg - prolonged-release tablet - 10 mg - alfuzosin hydrochloride 10 mg - alfuzosin

Xatral XL Tablet Prolonged Release 10mg Malta - angļu - Malta Medicines Authority

xatral xl tablet prolonged release 10mg

neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - alfuzosin hydrochloride - prolonged-release tablet - alfuzosin hydrochloride 10 mg - urologicals

ALFUZOSIN ER TEVA  10 MG Izraēla - angļu - Ministry of Health

alfuzosin er teva 10 mg

teva israel ltd - alfuzosin hydrochloride - tablets extended release - alfuzosin hydrochloride 10 mg - alfuzosin - treatment of certain functional symptoms of benign prostatic hypertrophy particularly if surgery has to be delayed for some reason. adjuvant treatment to a catheter in acute urinary retention related to benign prostatic hypertrophy.